The Directorate General of Trade Remedies (DGTR) initiated an anti-dumping investigation on 28 September 2026 into imports of Penicillin G and its salts from China
The applicant, Lyfius Pharma Pvt Ltd, alleges 'material retardation' to the establishment of a domestic industry; its Kakinada plant has a capacity of 15,000 tonnes a year
The period of investigation is 1 April 2025 to 31 March 2026; no duty has been imposed yet
It is one of seven anti-dumping probes opened against Chinese products between 23 and 28 September 2026, four of them on pharmaceutical ingredients
DGTR only recommends a duty; the Ministry of Finance takes the final decision
Dumping is exporting a product below its normal value in the home market. Injury can take three forms: material injury, threat of injury, or material retardation, where dumped imports prevent a new domestic industry from establishing itself.
Simple Analogy: A big shop sells below cost so the new shop next door never gets going.
Empowers the Central Government to levy anti-dumping duty, not exceeding the margin of dumping, ordinarily for five years
Lay down how DGTR initiates and conducts an investigation and determines dumping, injury and causal link
Permits a duty only when dumping, injury to the domestic industry and a causal link between them are established
Single authority for anti-dumping, countervailing and safeguard investigations; formed in May 2018 by merging the Directorate General of Anti-Dumping and Allied Duties with the safeguards wings; attached office of the Department of Commerce, Ministry of Commerce and Industry
Takes the final decision and notifies the duty after DGTR's recommendation
Cut import dependence in 41 critical bulk drugs
Key: Approved in 2020 with an outlay of ₹6,940 crore; run by the Department of Pharmaceuticals; Lyfius's 15,000-tonne Penicillin G plant at Kakinada, inaugurated virtually by the Prime Minister on 29 October 2024, was set up under it and revived domestic production after about three decades
| Remedy | Targets | Provision in Customs Tariff Act, 1975 |
|---|---|---|
| Anti-dumping duty | Imports priced below normal value | Section 9A |
| Countervailing duty | Imports subsidised by the exporting country's government | Section 9 |
| Safeguard duty | A sudden surge in imports, even if fairly priced | Section 8B |
GS Paper III > Economy > External sector, trade policy and WTO
General Awareness > Economy > Trade remedies and regulators
The comparable price of the product in the exporter's home market
Normal value minus export price; the ceiling for the duty
The basic chemical building block from which a drug's active ingredient is made